Firmenbeschreibung
Vertex Pharmaceuticals Inc. ist ein globales Biotech-Unternehmen, das sich der Entdeckung und Entwicklung kleinmolekularer Arzneimittel zur Behandlung von schweren Erkrankungen verschrieben hat. Die Strategie des Unternehmens besteht aus der Vermarktung seiner Produkte sowohl unabhängig als auch gemeinsam mit führenden Pharmakonzernen. Die Produktpipeline von Vertex ist hauptsächlich auf Virusinfektionen, Entzündungen, Autoimmunkrankheiten und Krebs ausgerichtet. Vertex vermarktet den HIV-Proteasehemmer Lexiva gemeinsam mit GlaxoSmithKline.
KeyData
endOfFinancialYear: | 31.12.2024 01:00 |
stockholderStructure: | Capital World Investors (11.03%),Vanguard Group Inc (9.06%),Blackrock Inc. (8.5%),State Street Corporation (4.67%),Capital Research Global Investors (4.06%),FMR, LLC (3.59%),JP Morgan Chase & Company (2.46%),Wellington Management Group, LLP (2.3%),Geode Capital Management, LLC (2.2%),Jennison Associates LLC (1.68%) |
sharesOutstanding: | 256789869.0000 |
ceo: | Reshma Kewalramani, M.D. |
board: | Charles F. Wagner, Jr., David Altshuler, Stuart A. Arbuckle, Jonathan Biller, Carmen Bozic, Amit K. Sachdev, Bastiano Sanna, Nia Tatsis, E. Morrey Atkinson, Ph.D. |
supervisoryBoard: | Dr. Jeffrey Leiden, Bruce I. Sachs, Diana McKenzie, Dr. Alan Garber, Dr. Sangeeta N. Bhatia, Lloyd Carney, Reshma Kewalramani, Terrence C. Kearney, Suketu (Suky) Upadhyay |
countryID: | 20 |
freeFloat: | 82.7000 |
faceValue: | 0.0100 |
faceValueCurrencyID: | 4 |
faceValueCurrency: | USD |
sectorName: | Pharmazeutische Industrie |
industryName: | Gesundheitswesen |
subsectorName: | Pharmazeutische Industrie |
country: | USA |
countryName: | USA |
Kontakt
name: | Susie Lisa |
phone: | +1-617-341-6108 |
email: | investorinfo@vrtx.com |
irWebSite: | https://investors.vrtx.com/ |
Adresse
street: | 50 Northern Avenue |
city: | Boston, Massachusetts 02210, USA |
phone: | +1-617-961-7163 |
webSite: | www.vrtx.com/ |
email: | Investorinfo@VRTX.com |
webcastsWebSite: | https://investors.vrtx.com/events-presentations |
Finanzen (kurz)
year: | 2022 | cash: | 10504.0000 |
balanceSheetTotal: | 18150.9000 | liabilities: | 4238.2000 |
shareCapital: | 2.6000 | totalShareholdersEquity: | 13912.7000 |
sales: | 8930.7000 | incomeBeforeTaxes: | 4232.4000 |
netIncome: | 3322.0000 | cashFlow: | 3711.9000 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
year: | 2023 | cash: | 10369.1000 |
balanceSheetTotal: | 22730.2000 | liabilities: | 5149.8000 |
shareCapital: | 2.6000 | totalShareholdersEquity: | 17580.4000 |
sales: | 9869.2000 | incomeBeforeTaxes: | 4379.8000 |
netIncome: | 3619.6000 | cashFlow: | -139.7000 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
year: | 2024 | cash: | 4569.6000 |
balanceSheetTotal: | 22533.2000 | liabilities: | 6123.6000 |
shareCapital: | 2.6000 | totalShareholdersEquity: | 16409.6000 |
sales: | 11020.1000 | incomeBeforeTaxes: | 248.5000 |
netIncome: | -535.6000 | cashFlow: | -5800.1000 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
Finanzen (kurz)
year: | 2022 |
cash: | 10504.0000 |
balanceSheetTotal: | 18150.9000 |
liabilities: | 4238.2000 |
shareCapital: | 2.6000 |
totalShareholdersEquity: | 13912.7000 |
sales: | 8930.7000 |
incomeBeforeTaxes: | 4232.4000 |
netIncome: | 3322.0000 |
cashFlow: | 3711.9000 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2023 |
cash: | 10369.1000 |
balanceSheetTotal: | 22730.2000 |
liabilities: | 5149.8000 |
shareCapital: | 2.6000 |
totalShareholdersEquity: | 17580.4000 |
sales: | 9869.2000 |
incomeBeforeTaxes: | 4379.8000 |
netIncome: | 3619.6000 |
cashFlow: | -139.7000 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2024 |
cash: | 4569.6000 |
balanceSheetTotal: | 22533.2000 |
liabilities: | 6123.6000 |
shareCapital: | 2.6000 |
totalShareholdersEquity: | 16409.6000 |
sales: | 11020.1000 |
incomeBeforeTaxes: | 248.5000 |
netIncome: | -535.6000 |
cashFlow: | -5800.1000 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
Finanzen (ausführlich)
year: | 2023 | units: | 1000000 |
balanceSheetTotal: | 22730.2000 | cash: | 10369.1000 |
currentAssets: | 14144.2000 | fixedAssets: | 8586.0000 |
liabilities: | 3547.4000 | totalLiabilitiesEquity: | 22730.2000 |
totalShareholdersEquity: | 17580.4000 | property: | 1159.3000 |
intangibleAssets: | 839.9000 | longTermInvestments: | 2497.8000 |
inventories: | 738.8000 | accountsReceivable: | 1563.4000 |
accountsPayable: | 364.9000 | liabilitiesTotal: | 5149.8000 |
longTermDebt: | 376.1000 | commonStock: | 2.6000 |
preferredStock: | 0.0000 | sales: | 9869.2000 |
depreciation: | 181.3000 | netIncome: | 3619.6000 |
operatingResult: | 3832.0000 | incomeInterest: | 44.1000 |
investments: | 3162.9000 | incomeTaxes: | 760.2000 |
costGoodsSold: | 1262.2000 | grossProfit: | 8607.0000 |
cashFlow: | 3537.3000 | cashFlowInvesting: | -3141.7000 |
cashFlowFinancing: | -562.2000 | cashFlowTotal: | -139.7000 |
accountingStandard: | US GAAP | equityRatio: | 77.3438 |
debtEquityRatio: | 0.0214 | liquidityI: | 2.9230 |
liquidityII: | 3.3637 | netMargin: | 36.6757 |
grossMargin: | 87.2107 | cashFlowMargin: | 35.8418 |
ebitMargin: | 38.8279 | ebitdaMargin: | 0.0000 |
preTaxROE: | 24.9130 | preTaxROA: | 19.2686 |
roe: | 20.5888 | roa: | 15.9242 |
netIncomeGrowth: | 8.9585 | revenuesGrowth: | 10.5087 |
taxExpenseRate: | 17.3570 | equityTurnover: | 0.5614 |
epsBasic: | 14.0500 | epsDiluted: | 13.8900 |
epsBasicGrowth: | 8.3269 | shareCapital: | 2.6000 |
incomeBeforeTaxes: | 4379.8000 | priceEarningsRatioCompany: | 28.9601 |
priceCashFlowRatio: | 29.7127 | bookValuePerShare: | 68.0599 |
marketCap: | 105102867252.2400 | earningsYield: | 3.4530 |
pegRatio: | 3.4779 | cashFlowPerShare: | 13.6941 |
priceBookValueRatio: | 5.9784 | priceEarningsRatio: | 29.0371 |
netEarningsPerShare: | 14.0127 | currency: | USD |
year: | 2024 | units: | 1000000 |
balanceSheetTotal: | 22533.2000 | cash: | 4569.6000 |
currentAssets: | 9596.4000 | fixedAssets: | 12936.8000 |
liabilities: | 3564.6000 | totalLiabilitiesEquity: | 22533.2000 |
totalShareholdersEquity: | 16409.6000 | property: | 1227.8000 |
intangibleAssets: | 825.9000 | longTermInvestments: | 5107.9000 |
inventories: | 1205.4000 | accountsReceivable: | 1609.4000 |
accountsPayable: | 413.0000 | liabilitiesTotal: | 6123.6000 |
longTermDebt: | 112.8000 | commonStock: | 2.6000 |
preferredStock: | 0.0000 | sales: | 11020.1000 |
depreciation: | 207.2000 | netIncome: | -535.6000 |
operatingResult: | -232.9000 | investments: | 3630.3000 |
incomeTaxes: | 784.1000 | costGoodsSold: | 1530.5000 |
grossProfit: | 9489.6000 | cashFlow: | -492.6000 |
cashFlowInvesting: | -3770.0000 | cashFlowFinancing: | -1494.9000 |
cashFlowTotal: | -5800.1000 | accountingStandard: | US GAAP |
equityRatio: | 72.8241 | debtEquityRatio: | 0.0069 |
liquidityI: | 1.2819 | liquidityII: | 1.7334 |
netMargin: | -4.8602 | grossMargin: | 86.1117 |
cashFlowMargin: | -4.4700 | ebitMargin: | -2.1134 |
ebitdaMargin: | 0.0000 | preTaxROE: | 1.5144 |
preTaxROA: | 1.1028 | roe: | -3.2639 |
roa: | -2.3769 | netIncomeGrowth: | -114.7972 |
revenuesGrowth: | 11.6615 | taxExpenseRate: | 315.5332 |
equityTurnover: | 0.6716 | epsBasic: | -2.0800 |
epsDiluted: | -2.0800 | epsBasicGrowth: | -114.8043 |
shareCapital: | 2.6000 | incomeBeforeTaxes: | 248.5000 |
priceCashFlowRatio: | -209.9255 | bookValuePerShare: | 63.9028 |
marketCap: | 103409280246.3000 | earningsYield: | -0.5165 |
cashFlowPerShare: | -1.9183 | priceBookValueRatio: | 6.3018 |
netEarningsPerShare: | -2.0858 | currency: | USD |
year: | 2025 | priceCashFlowRatio: | -254.9653 |
bookValuePerShare: | 63.9028 | marketCap: | 125595924927.9000 |
earningsYield: | -0.4253 | pegRatio: | 2.0482 |
cashFlowPerShare: | -1.9183 | netAssetsPerShare: | 63.9028 |
priceBookValueRatio: | 7.6538 | netEarningsPerShare: | -2.0858 |
currency: | USD |
Finanzen (ausführlich)
year: | 2023 |
units: | 1000000 |
balanceSheetTotal: | 22730.2000 |
cash: | 10369.1000 |
currentAssets: | 14144.2000 |
fixedAssets: | 8586.0000 |
liabilities: | 3547.4000 |
totalLiabilitiesEquity: | 22730.2000 |
totalShareholdersEquity: | 17580.4000 |
property: | 1159.3000 |
intangibleAssets: | 839.9000 |
longTermInvestments: | 2497.8000 |
inventories: | 738.8000 |
accountsReceivable: | 1563.4000 |
accountsPayable: | 364.9000 |
liabilitiesTotal: | 5149.8000 |
longTermDebt: | 376.1000 |
commonStock: | 2.6000 |
preferredStock: | 0.0000 |
sales: | 9869.2000 |
depreciation: | 181.3000 |
netIncome: | 3619.6000 |
operatingResult: | 3832.0000 |
incomeInterest: | 44.1000 |
investments: | 3162.9000 |
incomeTaxes: | 760.2000 |
costGoodsSold: | 1262.2000 |
grossProfit: | 8607.0000 |
cashFlow: | 3537.3000 |
cashFlowInvesting: | -3141.7000 |
cashFlowFinancing: | -562.2000 |
cashFlowTotal: | -139.7000 |
accountingStandard: | US GAAP |
equityRatio: | 77.3438 |
debtEquityRatio: | 0.0214 |
liquidityI: | 2.9230 |
liquidityII: | 3.3637 |
netMargin: | 36.6757 |
grossMargin: | 87.2107 |
cashFlowMargin: | 35.8418 |
ebitMargin: | 38.8279 |
ebitdaMargin: | 0.0000 |
preTaxROE: | 24.9130 |
preTaxROA: | 19.2686 |
roe: | 20.5888 |
roa: | 15.9242 |
netIncomeGrowth: | 8.9585 |
revenuesGrowth: | 10.5087 |
taxExpenseRate: | 17.3570 |
equityTurnover: | 0.5614 |
epsBasic: | 14.0500 |
epsDiluted: | 13.8900 |
epsBasicGrowth: | 8.3269 |
shareCapital: | 2.6000 |
incomeBeforeTaxes: | 4379.8000 |
priceEarningsRatioCompany: | 28.9601 |
priceCashFlowRatio: | 29.7127 |
bookValuePerShare: | 68.0599 |
marketCap: | 105102867252.2400 |
earningsYield: | 3.4530 |
pegRatio: | 3.4779 |
cashFlowPerShare: | 13.6941 |
priceBookValueRatio: | 5.9784 |
priceEarningsRatio: | 29.0371 |
netEarningsPerShare: | 14.0127 |
currency: | USD |
year: | 2024 |
units: | 1000000 |
balanceSheetTotal: | 22533.2000 |
cash: | 4569.6000 |
currentAssets: | 9596.4000 |
fixedAssets: | 12936.8000 |
liabilities: | 3564.6000 |
totalLiabilitiesEquity: | 22533.2000 |
totalShareholdersEquity: | 16409.6000 |
property: | 1227.8000 |
intangibleAssets: | 825.9000 |
longTermInvestments: | 5107.9000 |
inventories: | 1205.4000 |
accountsReceivable: | 1609.4000 |
accountsPayable: | 413.0000 |
liabilitiesTotal: | 6123.6000 |
longTermDebt: | 112.8000 |
commonStock: | 2.6000 |
preferredStock: | 0.0000 |
sales: | 11020.1000 |
depreciation: | 207.2000 |
netIncome: | -535.6000 |
operatingResult: | -232.9000 |
investments: | 3630.3000 |
incomeTaxes: | 784.1000 |
costGoodsSold: | 1530.5000 |
grossProfit: | 9489.6000 |
cashFlow: | -492.6000 |
cashFlowInvesting: | -3770.0000 |
cashFlowFinancing: | -1494.9000 |
cashFlowTotal: | -5800.1000 |
accountingStandard: | US GAAP |
equityRatio: | 72.8241 |
debtEquityRatio: | 0.0069 |
liquidityI: | 1.2819 |
liquidityII: | 1.7334 |
netMargin: | -4.8602 |
grossMargin: | 86.1117 |
cashFlowMargin: | -4.4700 |
ebitMargin: | -2.1134 |
ebitdaMargin: | 0.0000 |
preTaxROE: | 1.5144 |
preTaxROA: | 1.1028 |
roe: | -3.2639 |
roa: | -2.3769 |
netIncomeGrowth: | -114.7972 |
revenuesGrowth: | 11.6615 |
taxExpenseRate: | 315.5332 |
equityTurnover: | 0.6716 |
epsBasic: | -2.0800 |
epsDiluted: | -2.0800 |
epsBasicGrowth: | -114.8043 |
shareCapital: | 2.6000 |
incomeBeforeTaxes: | 248.5000 |
priceCashFlowRatio: | -209.9255 |
bookValuePerShare: | 63.9028 |
marketCap: | 103409280246.3000 |
earningsYield: | -0.5165 |
cashFlowPerShare: | -1.9183 |
priceBookValueRatio: | 6.3018 |
netEarningsPerShare: | -2.0858 |
currency: | USD |
year: | 2025 |
priceCashFlowRatio: | -254.9653 |
bookValuePerShare: | 63.9028 |
marketCap: | 125595924927.9000 |
earningsYield: | -0.4253 |
pegRatio: | 2.0482 |
cashFlowPerShare: | -1.9183 |
netAssetsPerShare: | 63.9028 |
priceBookValueRatio: | 7.6538 |
netEarningsPerShare: | -2.0858 |
currency: | USD |